• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真实世界数据驾驶舱:真实世界数据质量评估应用程序。

RWD-Cockpit: Application for Quality Assessment of Real-world Data.

作者信息

Babrak Lmar Marie, Smakaj Erand, Agac Teyfik, Asprion Petra Maria, Grimberg Frank, der Werf Daan Van, van Ginkel Erwin Willem, Tosoni Deniz David, Clay Ieuan, Degen Markus, Brodbeck Dominique, Natali Eriberto Noel, Schkommodau Erik, Miho Enkelejda

机构信息

University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, Muttenz, Switzerland.

Fachhochschule Nordwestschweiz University of Applied Sciences and Arts Northwestern Switzerland, School of Business, Olten, Switzerland.

出版信息

JMIR Form Res. 2022 Oct 18;6(10):e29920. doi: 10.2196/29920.

DOI:10.2196/29920
PMID:35266872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9627468/
Abstract

BACKGROUND

Digital technologies are transforming the health care system. A large part of information is generated as real-world data (RWD). Data from electronic health records and digital biomarkers have the potential to reveal associations between the benefits and adverse events of medicines, establish new patient-stratification principles, expose unknown disease correlations, and inform on preventive measures. The impact for health care payers and providers, the biopharmaceutical industry, and governments is massive in terms of health outcomes, quality of care, and cost. However, a framework to assess the preliminary quality of RWD is missing, thus hindering the conduct of population-based observational studies to support regulatory decision-making and real-world evidence.

OBJECTIVE

To address the need to qualify RWD, we aimed to build a web application as a tool to translate characterization of some quality parameters of RWD into a metric and propose a standard framework for evaluating the quality of the RWD.

METHODS

The RWD-Cockpit systematically scores data sets based on proposed quality metrics and customizable variables chosen by the user. Sleep RWD generated de novo and publicly available data sets were used to validate the usability and applicability of the web application. The RWD quality score is based on the evaluation of 7 variables: manageability specifies access and publication status; complexity defines univariate, multivariate, and longitudinal data; sample size indicates the size of the sample or samples; privacy and liability stipulates privacy rules; accessibility specifies how the data set can be accessed and to what granularity; periodicity specifies how often the data set is updated; and standardization specifies whether the data set adheres to any specific technical or metadata standard. These variables are associated with several descriptors that define specific characteristics of the data set.

RESULTS

To address the need to qualify RWD, we built the RWD-Cockpit web application, which proposes a framework and applies a common standard for a preliminary evaluation of RWD quality across data sets-molecular, phenotypical, and social-and proposes a standard that can be further personalized by the community retaining an internal standard. Applied to 2 different case studies-de novo-generated sleep data and publicly available data sets-the RWD-Cockpit could identify and provide researchers with variables that might increase quality.

CONCLUSIONS

The results from the application of the framework of RWD metrics implemented in the RWD-Cockpit application suggests that multiple data sets can be preliminarily evaluated in terms of quality using the proposed metrics. The output scores-quality identifiers-provide a first quality assessment for the use of RWD. Although extensive challenges remain to be addressed to set RWD quality standards, our proposal can serve as an initial blueprint for community efforts in the characterization of RWD quality for regulated settings.

摘要

背景

数字技术正在改变医疗保健系统。很大一部分信息以真实世界数据(RWD)的形式产生。来自电子健康记录和数字生物标志物的数据有可能揭示药物的益处与不良事件之间的关联,确立新的患者分层原则,揭示未知的疾病相关性,并为预防措施提供依据。对医疗保健支付方和提供者、生物制药行业以及政府而言,在健康结果、护理质量和成本方面,其影响是巨大的。然而,目前缺少一个评估RWD初步质量的框架,这阻碍了开展基于人群的观察性研究以支持监管决策和真实世界证据。

目的

为满足对RWD进行质量评估的需求,我们旨在构建一个网络应用程序,作为将RWD某些质量参数的特征转化为一种度量标准的工具,并提出一个评估RWD质量的标准框架。

方法

RWD-Cockpit根据提议的质量指标和用户选择的可定制变量对数据集进行系统评分。使用新生成的睡眠RWD和公开可用的数据集来验证该网络应用程序的可用性和适用性。RWD质量评分基于对7个变量的评估:可管理性规定了访问和发布状态;复杂性定义了单变量、多变量和纵向数据;样本量表明样本或多个样本的大小;隐私和责任规定了隐私规则;可访问性规定了如何访问数据集以及访问的粒度;周期性规定了数据集更新的频率;标准化规定了数据集是否符合任何特定的技术或元数据标准。这些变量与多个描述符相关联,这些描述符定义了数据集的特定特征。

结果

为满足对RWD进行质量评估的需求,我们构建了RWD-Cockpit网络应用程序,它提出了一个框架,并应用一个通用标准对跨数据集(分子、表型和社会数据集)的RWD质量进行初步评估,并提出了一个可由社区进一步个性化定制的标准,同时保留内部标准。应用于2个不同的案例研究——新生成的睡眠数据和公开可用的数据集——RWD-Cockpit能够识别并为研究人员提供可能提高质量的变量。

结论

在RWD-Cockpit应用程序中实施的RWD指标框架的应用结果表明,可以使用提议的指标对多个数据集的质量进行初步评估。输出分数——质量标识符——为RWD的使用提供了首次质量评估。尽管在设定RWD质量标准方面仍有诸多挑战有待解决,但我们的提议可为社区在规范环境中表征RWD质量的努力提供一个初步蓝图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/97673044bca3/formative_v6i10e29920_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/fba3fcd49dc6/formative_v6i10e29920_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/a5e960cd947e/formative_v6i10e29920_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/97673044bca3/formative_v6i10e29920_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/fba3fcd49dc6/formative_v6i10e29920_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/a5e960cd947e/formative_v6i10e29920_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bce/9627468/97673044bca3/formative_v6i10e29920_fig3.jpg

相似文献

1
RWD-Cockpit: Application for Quality Assessment of Real-world Data.真实世界数据驾驶舱:真实世界数据质量评估应用程序。
JMIR Form Res. 2022 Oct 18;6(10):e29920. doi: 10.2196/29920.
2
Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.临床数据交换标准协会(CDISC)标准在真实世界数据中的应用:来自定性德尔菲调查的专家观点
JMIR Med Inform. 2022 Jan 27;10(1):e30363. doi: 10.2196/30363.
3
It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.需要注意的是,真实世界数据(RWD)永远无法取代更为传统且更为可靠的随机对照试验(RCT)数据;然而,新出现的趋势是纳入更具普遍性的数据。引言。
J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4.
4
Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study.真实世界数据在回答乳腺癌脑转移主要临床研究问题中的初步可获得性评估:框架开发和验证研究。
J Med Internet Res. 2023 Mar 23;25:e43359. doi: 10.2196/43359.
5
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
6
A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-making.国家评估分析和专家访谈研究现实世界的数据来源,用于研究和医疗保健决策。
Sci Rep. 2024 Apr 28;14(1):9751. doi: 10.1038/s41598-024-59475-9.
7
Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union.美国和欧盟医疗保健领域的真实世界数据与真实世界证据
Bioengineering (Basel). 2024 Aug 2;11(8):784. doi: 10.3390/bioengineering11080784.
8
Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.真实世界数据管理的数据治理:支持决策制定的检查表提案。
Value Health. 2023 Apr;26(4S):32-42. doi: 10.1016/j.jval.2023.02.012. Epub 2023 Mar 2.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Lessons on the use of real-world data in medical device research: findings from the National Evaluation System for Health Technology Test-Cases.医疗器械研究中真实世界数据应用的经验教训:国家卫生技术评估实例研究评价系统的研究结果。
J Comp Eff Res. 2024 Sep;13(9):e240078. doi: 10.57264/cer-2024-0078. Epub 2024 Aug 16.

引用本文的文献

1
Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus.药物研究与医疗保健决策中真实世界数据的质量标准:奥地利专家共识
JMIR Med Inform. 2022 Jun 17;10(6):e34204. doi: 10.2196/34204.

本文引用的文献

1
The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.真实世界数据挑战雷达:关于真实世界数据使用的挑战与风险综述
Digit Biomark. 2021 Jun 24;5(2):148-157. doi: 10.1159/000516178. eCollection 2021 May-Aug.
2
Real-world Data to Generate Evidence About Healthcare Interventions: The Application of an Ethics Framework for Big Data in Health and Research.生成医疗保健干预证据的真实世界数据:大数据伦理框架在健康与研究中的应用。
Asian Bioeth Rev. 2019 Sep 4;11(3):289-298. doi: 10.1007/s41649-019-00095-1. eCollection 2019 Sep.
3
Evaluation Criteria for Weight Management Apps: Validation Using a Modified Delphi Process.
体重管理应用程序的评估标准:使用改良 Delphi 法进行验证。
JMIR Mhealth Uhealth. 2020 Jul 22;8(7):e16899. doi: 10.2196/16899.
4
Methods and Evaluation Criteria for Apps and Digital Interventions for Diabetes Self-Management: Systematic Review.糖尿病自我管理应用程序和数字干预措施的方法及评估标准:系统评价
J Med Internet Res. 2020 Jul 6;22(7):e18480. doi: 10.2196/18480.
5
Considerations when evaluating real-world data quality in the context of fitness for purpose.在评估数据是否适用于实际用途的背景下,对现实世界数据质量进行评估时的考量因素。
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6.
6
Requirements of Health Data Management Systems for Biomedical Care and Research: Scoping Review.卫生数据管理系统在生物医学保健和研究中的要求:范围综述。
J Med Internet Res. 2020 Jul 7;22(7):e17508. doi: 10.2196/17508.
7
Use of Real-world Data for New Drug Applications and Line Extensions.真实世界数据在新药申请和适应症扩展中的应用。
Clin Ther. 2020 May;42(5):926-938. doi: 10.1016/j.clinthera.2020.03.006. Epub 2020 Apr 25.
8
Quantifying the use of connected digital products in clinical research.量化临床研究中联网数字产品的使用情况。
NPJ Digit Med. 2020 Apr 3;3:50. doi: 10.1038/s41746-020-0259-x. eCollection 2020.
9
Traditional and Digital Biomarkers: Two Worlds Apart?传统生物标志物与数字生物标志物:天壤之别?
Digit Biomark. 2019 Aug 16;3(2):92-102. doi: 10.1159/000502000. eCollection 2019 May-Aug.
10
Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation.关于在药物研发和监管中使用真实世界数据(RWD)和真实世界证据(RWE)的现状报告。
Br J Clin Pharmacol. 2019 Sep;85(9):1874-1877. doi: 10.1111/bcp.14026. Epub 2019 Jul 10.